...
uncy-img

Unicycive Therapeutics Inc, Common Stock

UNCY

NAQ

$0.663

-$0.02

(-2.92%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$71.00M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.23M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.29
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.2 L
$1.82 H
$0.663

About Unicycive Therapeutics Inc, Common Stock

Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameUNCYSectorS&P500
1-Week Return-5.29%-0.94%-2.6%
1-Month Return19.98%-5.08%-1.08%
3-Month Return55.85%-10.62%3.45%
6-Month Return-2.89%-6.18%8.57%
1-Year Return10.5%1.98%24.3%
3-Year Return-68.28%-0.93%25.58%
5-Year Return-86.74%33.84%84.07%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue---951.00K675.00K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":70.98,"profit":true}]
Cost of Revenue--1.00K7.00K284.00K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.35,"profit":true},{"date":"2022-12-31","value":2.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit--(1.00K)951.00K675.00K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.11,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":70.98,"profit":true}]
Gross Margin---100.00%100.00%[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses1.96M2.02M8.98M19.00M21.45M[{"date":"2019-12-31","value":9.15,"profit":true},{"date":"2020-12-31","value":9.42,"profit":true},{"date":"2021-12-31","value":41.85,"profit":true},{"date":"2022-12-31","value":88.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(1.96M)(2.02M)(8.98M)(18.05M)(20.77M)[{"date":"2019-12-31","value":-196300000,"profit":false},{"date":"2020-12-31","value":-202000000,"profit":false},{"date":"2021-12-31","value":-897700000,"profit":false},{"date":"2022-12-31","value":-1805200000,"profit":false},{"date":"2023-12-31","value":-2077400000,"profit":false}]
Total Non-Operating Income/Expense(341.00K)(488.00K)(1.67M)(12.00K)(9.36M)[{"date":"2019-12-31","value":-34100000,"profit":false},{"date":"2020-12-31","value":-48800000,"profit":false},{"date":"2021-12-31","value":-166800000,"profit":false},{"date":"2022-12-31","value":-1200000,"profit":false},{"date":"2023-12-31","value":-936100000,"profit":false}]
Pre-Tax Income(2.17M)(2.26M)(10.02M)(18.06M)(30.54M)[{"date":"2019-12-31","value":-216500000,"profit":false},{"date":"2020-12-31","value":-226400000,"profit":false},{"date":"2021-12-31","value":-1001700000,"profit":false},{"date":"2022-12-31","value":-1805800000,"profit":false},{"date":"2023-12-31","value":-3054400000,"profit":false}]
Income Taxes139.00K244.00K615.00K6.00K116.11K[{"date":"2019-12-31","value":22.6,"profit":true},{"date":"2020-12-31","value":39.67,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":0.98,"profit":true},{"date":"2023-12-31","value":18.88,"profit":true}]
Income After Taxes(2.30M)(2.51M)(10.63M)(18.06M)(30.66M)[{"date":"2019-12-31","value":-230400000,"profit":false},{"date":"2020-12-31","value":-250800000,"profit":false},{"date":"2021-12-31","value":-1063200000,"profit":false},{"date":"2022-12-31","value":-1806400000,"profit":false},{"date":"2023-12-31","value":-3066010500,"profit":false}]
Income From Continuous Operations(2.17M)(2.26M)(10.02M)(18.06M)(28.07M)[{"date":"2019-12-31","value":-216500000,"profit":false},{"date":"2020-12-31","value":-226400000,"profit":false},{"date":"2021-12-31","value":-1001700000,"profit":false},{"date":"2022-12-31","value":-1805800000,"profit":false},{"date":"2023-12-31","value":-2807400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(2.30M)(2.51M)(10.63M)(18.06M)(30.54M)[{"date":"2019-12-31","value":-230400000,"profit":false},{"date":"2020-12-31","value":-250800000,"profit":false},{"date":"2021-12-31","value":-1063200000,"profit":false},{"date":"2022-12-31","value":-1806400000,"profit":false},{"date":"2023-12-31","value":-3054400000,"profit":false}]
EPS (Diluted)--(0.57)(1.20)(0.92)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-57,"profit":false},{"date":"2022-12-31","value":-120,"profit":false},{"date":"2023-12-31","value":-92,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

UNCY
Cash Ratio 3.09
Current Ratio 3.61

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

UNCY
ROA (LTM) -53.37%
ROE (LTM) -121.76%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

UNCY
Debt Ratio Lower is generally better. Negative is bad. 0.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.72

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

UNCY
Trailing PE NM
Forward PE NM
P/S (TTM) 62.82
P/B 2.60
Price/FCF NM
EV/R 16.63
EV/Ebitda NM

FAQs

What is Unicycive Therapeutics Inc share price today?

Unicycive Therapeutics Inc (UNCY) share price today is $0.663

Can Indians buy Unicycive Therapeutics Inc shares?

Yes, Indians can buy shares of Unicycive Therapeutics Inc (UNCY) on Vested. To buy Unicycive Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in UNCY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Unicycive Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Unicycive Therapeutics Inc (UNCY) via the Vested app. You can start investing in Unicycive Therapeutics Inc (UNCY) with a minimum investment of $1.

How to invest in Unicycive Therapeutics Inc shares from India?

You can invest in shares of Unicycive Therapeutics Inc (UNCY) via Vested in three simple steps:

  • Click on Sign Up or Invest in UNCY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Unicycive Therapeutics Inc shares
What is Unicycive Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Unicycive Therapeutics Inc (UNCY) is $1.82. The 52-week low price of Unicycive Therapeutics Inc (UNCY) is $0.2.

What is Unicycive Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Unicycive Therapeutics Inc (UNCY) is

What is Unicycive Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Unicycive Therapeutics Inc (UNCY) is 2.60

What is Unicycive Therapeutics Inc dividend yield?

The dividend yield of Unicycive Therapeutics Inc (UNCY) is 0.00%

What is the Market Cap of Unicycive Therapeutics Inc?

The market capitalization of Unicycive Therapeutics Inc (UNCY) is $71.00M

What is Unicycive Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Unicycive Therapeutics Inc is UNCY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top